| 1 | LLY | Eli Lilly and Company | 9.50% |
| 2 | ABT | Abbott Laboratories | 4.71% |
| 3 | CPH: NOVO.B | Novo Nordisk A/S | 4.33% |
| 4 | LON: AZN | AstraZeneca PLC | 4.28% |
| 5 | RHHBY | Roche Holding AG | 3.94% |
| 6 | BSX | Boston Scientific Corporation | 3.74% |
| 7 | UNH | UnitedHealth Group Incorporated | 3.66% |
| 8 | VRTX | Vertex Pharmaceuticals Incorporated | 3.30% |
| 9 | GILD | Gilead Sciences, Inc. | 3.24% |
| 10 | SWX: NOVN | Novartis AG | 3.17% |
| 11 | BBIO | BridgeBio Pharma, Inc. | 3.10% |
| 12 | CRNX | Crinetics Pharmaceuticals, Inc. | 2.72% |
| 13 | MDT | Medtronic plc | 2.66% |
| 14 | TMO | Thermo Fisher Scientific Inc. | 2.65% |
| 15 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 2.50% |
| 16 | MRK | Merck & Co., Inc. | 2.49% |
| 17 | PODD | Insulet Corporation | 2.40% |
| 18 | ABBV | AbbVie Inc. | 2.30% |
| 19 | EW | Edwards Lifesciences Corporation | 2.24% |
| 20 | BMY | Bristol-Myers Squibb Company | 2.14% |
| 21 | REGN | Regeneron Pharmaceuticals, Inc. | 2.07% |
| 22 | MCK | McKesson Corporation | 2.03% |
| 23 | DHR | Danaher Corporation | 2.00% |
| 24 | ALNY | Alnylam Pharmaceuticals, Inc. | 1.97% |
| 25 | AMGN | Amgen Inc. | 1.78% |
| View HRTS holdings |